E
Oaktree Acquisition Corp. III Life Sciences OACC
$10.44 -$0.01-0.10% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025
Total Cash And Short-Term Investments --
Total Receivables --
Inventory --
Prepaid Expenses --
Finance Division Loans and Leases Current --
Total Finance Division Other Current Assets --
Other Current Assets --
Total Current Assets --

Total Current Assets --
Net Property, Plant & Equipment --
Long-term Investments --
Goodwill --
Total Other Intangibles --
Finance Div Loans & Leases LT --
Total Finance Div Other LT Assets --
Total Other Assets 203,626.29%
Total Assets 205,235.77%

Total Accounts Payable --
Total Accrued Expenses --
Short-term Debt --
Current Portion of Long-Term Debt/Capital Leases --
Finance Division Debt Current --
Total Finance Division Other Current Liabilities 908.19%
Total Other Current Liabilities 908.19%
Total Current Liabilities 1,151.90%

Total Current Liabilities 1,151.90%
Long-Term Debt --
Short-term Debt --
Capital Leases --
Finance Division Debt Non Current --
Total Finance Division Other Non Current Liabilities --
Total Other Liabilities --
Total Liabilities 230,006.04%

Common Stock & APIC -98.00%
Retained Earnings -37,483.91%
Treasury Stock & Other --
Total Common Equity -86,140.79%

Preferred Stock Redeemable --
Preferred Stock Non Redeemable --
Preferred Stock Convertible --
Preferred Stock, Others --
Total Preferred Equity --

Total Common Equity -86,140.79%
Total Preferred Equity --
Total Minority Interest --
Total Equity -86,140.79%